EUR 8.7
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - EUR | 0.0% |
2022 | - EUR | 0.0% |
2021 | - EUR | -100.0% |
2020 | 12.1 Million EUR | 10.0% |
2019 | 11 Million EUR | 3.77% |
2018 | 10.6 Million EUR | -23.19% |
2017 | 13.8 Million EUR | -0.72% |
2016 | 13.9 Million EUR | -0.71% |
2015 | 14 Million EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - EUR | 0.0% |
2024 Q1 | - EUR | 0.0% |
2023 Q1 | - EUR | 0.0% |
2023 FY | - EUR | 0.0% |
2023 Q3 | - EUR | 0.0% |
2023 Q4 | - EUR | 0.0% |
2023 Q2 | - EUR | 0.0% |
2022 Q4 | - EUR | 0.0% |
2022 Q2 | - EUR | 0.0% |
2022 FY | - EUR | 0.0% |
2022 Q1 | - EUR | 0.0% |
2022 Q3 | - EUR | 0.0% |
2021 Q4 | - EUR | 0.0% |
2021 FY | - EUR | -100.0% |
2021 Q3 | - EUR | 0.0% |
2021 Q2 | - EUR | -100.0% |
2021 Q1 | 1.00 EUR | -100.0% |
2020 Q2 | 12.7 Million EUR | 0.0% |
2020 Q4 | 12.1 Million EUR | 0.0% |
2020 FY | 12.1 Million EUR | 10.0% |
2020 Q3 | 12.1 Million EUR | -4.72% |
2020 Q1 | 12.7 Million EUR | 15.45% |
2019 Q4 | 11 Million EUR | 0.0% |
2019 FY | 11 Million EUR | 3.77% |
2019 Q3 | 11 Million EUR | -9.84% |
2019 Q2 | 12.2 Million EUR | 0.0% |
2019 Q1 | 12.2 Million EUR | 15.09% |
2018 Q2 | 11.7 Million EUR | 0.0% |
2018 Q4 | 10.6 Million EUR | 0.0% |
2018 FY | 10.6 Million EUR | -23.19% |
2018 Q1 | 11.7 Million EUR | -15.22% |
2018 Q3 | 10.6 Million EUR | -9.4% |
2017 Q2 | 11.9 Million EUR | 0.0% |
2017 FY | 13.8 Million EUR | -0.72% |
2017 Q3 | 13.8 Million EUR | 15.97% |
2017 Q4 | 13.8 Million EUR | 0.0% |
2017 Q1 | 11.9 Million EUR | -14.39% |
2016 Q3 | 13.9 Million EUR | 2.96% |
2016 Q2 | 13.5 Million EUR | 0.0% |
2016 FY | 13.9 Million EUR | -0.71% |
2016 Q1 | 13.5 Million EUR | -3.57% |
2016 Q4 | 13.9 Million EUR | 0.0% |
2015 Q2 | 15.4 Million EUR | 0.0% |
2015 FY | 14 Million EUR | 0.0% |
2015 Q4 | 14 Million EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AB Science S.A. | 336 Thousand EUR | 100.0% |
Boiron SA | 96.76 Million EUR | 100.0% |
Fagron NV | 113.93 Million EUR | 100.0% |
Ipsen S.A. | 289.5 Million EUR | 100.0% |
Vetoquinol SA | 103.53 Million EUR | 100.0% |